Trade Mark Journal No.2021/053 31 December 2021

WO0000001631366 (5)

Office of origin: United States of America

Date of International Registration:9 November 2021
Date of designation in the UK: 9 November 2021
Image for mark 1631366 TAYSHA GENE THERAPIES

International priority date claimed: 15 June 2021 (United States of America) (90773805)
Class 5
Pharmaceuticals and pharmaceutical preparations for use in the treatment of genetic diseases and disorders.

Taysha Gene Therapies, Inc.

Representative: John L. DuPre' Hamilton, Brook, Smith & Reynolds, P.C., 530 Virginia Road, P.O. Box 9133, Concord MA 01742-9133, UNITED STATES OF AMERICA